This study provides evidence for further elucidation of VDBP targeting specific molecular markers of inhibitory neuron subtypes involved in the occurrence of depression and targeted interventions, further supporting the value of brain‐derived VDBP as a biomarker for the diagnosis of depressive disorder. The gene discussed is GC; the disease is depressive symptom measurement.